B2B healthtech startup Medikabazaar has raised $75 million in a Series C round led by UK-based development finance institution CDC Group and PE fund Creaegis.
The round also saw participation from existing investors, including Belgium-based Ackermans & van Haaren (AvH), HealthQuad Advisors, Japan-based Rebright Partners, Continental Europe-based Kois Holdings, and Sumitomo Mitsui Financial Group. This is one of the largest deals in the B2B healthcare space in India.
Mumbai-based healthtech startup Medikabazaar will use this funding to deepen its supply ecosystem and tech-led distribution channels across geographies. Prior to this, Medikabazaar had raised a Series B round of $15.8 million in 2019.
